Canada Life’s Asensus Surgical, Inc. ASXC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-2,465
Closed -$44K 2384
2019
Q2
$44K Hold
2,465
﹤0.01% 2472
2019
Q1
$75K Hold
2,465
﹤0.01% 2155
2018
Q4
$70K Buy
+2,465
New +$112K ﹤0.01% 2264
2017
Q2
Sell
-454
Closed -$7K 2550
2017
Q1
$7K Hold
454
﹤0.01% 2502
2016
Q4
$8K Hold
454
﹤0.01% 2527
2016
Q3
$10K Hold
454
﹤0.01% 2492
2016
Q2
$7K Buy
+454
New +$14.3K ﹤0.01% 2502
2015
Q3
Sell
-110,782
Closed -$4.31M 2603
2015
Q2
$4.31M Buy
+110,782
New +$5.1M 0.01% 664

Other funds holding ASXC

Canada Life's ASXC Position: Q3 2019 in Review

Canada Life sold out of Asensus Surgical, Inc. (ASXC) in Q3 2019, closing a stake of 2,465 shares — an estimated $44K sold.

Canada Life first reported a position in ASXC in Q2 2015 and held it in 8 quarters. The position peaked at $4.31M in Q2 2015. 130 funds tracked by Wall St. Rank hold ASXC as of Q3 2019.

  • Canada Life reported no remaining Asensus Surgical, Inc. position as of Q3 2019 after selling out during the quarter.
  • Canada Life sold 2,465 Asensus Surgical, Inc. shares in Q3 2019, an estimated $44K.
  • Canada Life first reported a position in Asensus Surgical, Inc. in Q2 2015 and held it in 8 quarters.
  • Canada Life's Asensus Surgical, Inc. position peaked at $4.31M in Q2 2015.
  • 130 funds tracked by Wall St. Rank held Asensus Surgical, Inc. as of Q3 2019.

Based on Canada Life's 13F filing for Q3 2019, filed 25 Oct 2019.